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lNT.RODUCTION 1. 
After a cursory perusal of any textbook or monograph, l have 
always read the introduction before making any concentrated e1Tort to 
digest the contents. The incentive prompting an individual to write any 
document is most interesting to me, and this usually manifests itself 
in the author's explanatory introduction or pre1·ace. Many times it is 
because the author sore.Ly 1·ee.ls the need of a more comprehensive work 
on a particular subject, other times because he desires to incorporate 
for posterity certain observations and facts noticeably omitted by 
other authors, or even, perhaps, to give vent to a literary inclination. 
l must confess that none of these reasons prompted my work. This paper 
is required - but I have attempted to present a nom-to-well understood 
subject, in as complete a manner as is possible under existing conditions 
and restrictions. bione or the material included herein is original, but 
numerous references to journals, textbooks, and monographs have assisted 
me in i'amiliarizing myself with the countless sources of in1'ormation at 
the disposal oi' one imbued with the scientific curiosity and ambition which 
if' exercised, will elevate the 11 symptom-treater11 to a more scientific 
student of medicine. 
I am gratei'ul to the office oi' JJrs. Lord, Schrock and Johnson, 
and the University Hospital, for the use of their 1'1.Les and the roentgeno-
gram photographs used herein. 
,-.I 
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HISTORY OF GIANT-CELL TUMOR 2. 
.-l 
Pare (75) in the 16th century described benign tumors of the maxilla 
which were cured by excision, Beclard (7) in 1827 a medullary, vascular, "not 
cancerous" bone tumour, and Warren in 1837 a benign central tumor of the femur. 
Lebert (58) in.1845 recognized giant cells in certain medullary tumors, and 
described yellow deposits in these masses as xanthosis, but did not differ-
entiate them from malignant sarcoma. Robin (81) in 1849 described two 
cellular elements of the medulla of bone which he called 11 cellules medullaires" 
and "cellules myeloplaques". The former were spherical or polyhedral, 0.015-
0.018 mm. in diameter, with a single nucleus of 6-7 microns,. the cytoplasm 
granular. They were more abundant in the young than in the old in the inter-
stices between the fat cells and vessels of the bone marrow. The latter type, 
11 cellules myeloplaques", he thought were a minimal normal constituent of adult 
and aged bone, becoming tumorous when in abundance. They are described as 
polygonal or irregular spheroids, 0.05-0.08 mm. in diameter, with finely granu-
lar cytoplasm containing six to ten nuclei, each of whicy had one or two 
nucleoli in their center. This is described first in a case of supposed 
"spina ventosa", an expansile tumor of the tibia. The term "spina ventosa" 
had been used also by Dupuytre~ for a similar lesion along with "fongus hema-
toids". Eugene R_elaton (71) considered that Robin deserved credit for the 
real identification of the "myeloplaques" as normal minor constituents of bone 
marrow. Lebert (SS) and Muller (70) had called the giant cells "mother cells"; 
Kolliker (54) considered them osteoclasts. 
lelaton (71) in his thesis of 186o offered a simple but none the 
less adequate definition of this neoplasm - 11 tumeur a myeloplaxes" - a 
particular kind of accidental tissue production whose fundamental architecture 
is characterized, not by simple presence of, but by the predominance of the 
,.,,..... 
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HISTORY OF GIANT-CELL TUMOR 
anatomic elements called "myeloplaques". 
From this point he proceeded to indicate four essential types of 
this class of tumor: 
(1) The solid or meaty (typical); 
(2) The fibroid, with more fibroblastic proliferation 
in the stroma; 
(3) The 11graisseuse" or xanthoid; 
(4) The vascular. 
The cystic changes not uncommonly seen were considered then as simple 
degeneration of the tumor. Such as showed hemorrhage into these cystic areas 
were considered the result of natural extravasation from the new-formed vessels 
of the tumor (probable so-called bone aneurysm). 
Gross (41) in 1879 reviewed the history and morphology of giant-cell 
sarcoma emphasizing, against Billroth's opinion, the benign prognostic import-
ance of giant-cell structure, and showing in four fatal cases that this tumor 
might become malignant. Gross' description of the origin, structure, clinical 
characters, and treatment of bone sarcoma stands today as the classic contri-
bution on this subject. 
v. Be:rgmann,Mickulicz and v. Bramann (9) recognized the benign nature 
of giant-cell tumors during the remaining few years of the 19th century. 
Hinds (47) in 1898, believing this tumor to be benign, successfully 
treated it by scraping and reported no recurrences after eighteen years of 
careful study. 
Bloodgood (12), Mallory (64) and Coley (23) are especially identified 
with the exhaustive study and recognition of giant-cell tumors, during the 
first part of the twentieth century. 
HISTORY OF GIANT-CELL TUMOR 
Various names have been given this lesion, beginning with tumeur a 
myeloplaxes by Nelaton (71), myeloid sarcoma - a name almost universally used 
from 1870 to 1910, and still used in British literature, hemorrhagic osseous 
dystrophia, giant-cell sarcoma, benign giant-cell sarcoma of the epulis type, 
-giant-cell sarcoid, giant-cell tumor (Bloodgood (12) , osteitis fibrosa cyslica 
(von Recklinghausen), hemorrhagic osteomyelitis (Barrie (2), and osteoclas-
toma (32)(36). The term most generally used today is giant-cell tumor or 
giant-cell sarcoma of the epulis type. Bloodgood (12) in 1912, after many 
years of extensive study and analysis of the condition writes, "It is my 
opinion that it might be well to drop Jhe term 'giant-cell sarcoma', as it 
gives a wrong impression of the malignancy of the lesion, and use, at least 
temporarily, the designation 'giant-cell tumor'." Mallory (64) also doubted 
the correctness of the term giant-cell sarcoma. Stewart (86) disagrees with 
Bloodgood who classifies them as benign giant-cell tumors, and also with Barrie 
who characterizes them as a type of hemorrhagic osteomyelitis. Stewart believes 
that the name myeloid sarcoma, as introduced by Paget (73) nearly seventy years 
ago, on account of the naked-eye resemblance of the tumor to red marrow, is 
the best name to apply to this group of tumors; and that since none of its 
constituent: cells is derived from specific bone marrow cells, the name "myeloma" 
is inaccurate and should be dropped. As it stands today, however, the majority 
of authors are using the Bone Registry's Classification and refer to this 
lesion as the benign giant-cell tumor of bone. 
ETIOLOGY O~ GIANT-CELL TUMOR 
The question of the etiology of giant-cell tumors is at first glance 
intricately interwoven with an academic question: Is giant-cell tumor a neo-
plasm or a product of inflammation and repair? The acceptance of the name 
giant-cell tumor as a substitute for all other names of this lesion is not 
to be looked upon as a proof of the neoplastic nature of the lesion; the 
term "tumor11 is used here merely in a clinical sense, that is, to indicate 
a swelling, inasmuch as the pathological anatomical sense of this word is 
at present not entirely clarified. The question of whether a giant-cell 
tumor is a true blastoma or merely an inflammatory process follows an old 
trodden path of discussion. Alexander and Crawford (1) state that it has 
at various times been considered the result of bone destruction due to 
spirochaete, tuberculosis, infectious bacteria and parasites, trauma, mal-
nutrition, and metabolic change. As it stands today, the concept of the 
disease known as giant-cell tumor divides investigators in two opposing 
classes. To one belong those who look upon giant-ce~ tumor as a true 
blastoma and to the other those who see in it merely a product of inflam-
mation and repair in bone •. Kolodny (55) believes that since the view upon 
giant-cell tumor as a true blastoma is supported by tradition, the burden 
of proof in this dispute lies on the promulgators of the inflammatory nature 
of giant-cell tumors. The leaders among these are Mallory, Codman, and 
Barrie in this country and Lubarsch and Konjetzny in Europe. Mallory (64) 
has long maintained that the giant cells of the giant-cell tumor are not an 
integral part of the lesion but only a biological reaction of the large 
mononuclears of the blood, the so-called endothelial leucocytes, which are 
found wherever retrograde changes are going on. As a reaction to calcium 
salts absorption, these endothelial leucocytes fuse and form the giant cells. 
ETIOLOGY OF GIANT-CELL TUMOR 6. 
Aside from these giant cells, no cells occur in these lesions which are not 
met with in ordinary inflammatory processes. 
Codman (21) sees in the giant-cell tumor a repair process follow-
ing intra-osseous hemorrhages due to rupture of nutrient vessels. In 
Codman's opinion the tendency of this disease to form expansive tumors does 
not warrant considering it as a neoplasm any more than does the enlargement 
of an aneurysm. Barrie (6) contends that the giant cells encountered in 
these lesions must be disregarded in attempting to reach a decision whether 
a process in bone should be considered either neoplastic or inflammatory, 
from the microscopist•s angle of investigation. "Such cells," he says, 
"are the known accompaniment both of inflammation and neoplastic disease; 
their presence, therefore, cannot be affirmative of tumor growth" 
Early efforts at repair in any non-suppurative area of osteolysis 
exhibits a picture similar to the process termed hemorrhagic osteomyelitis 
or giant-cell tumor. The same type of hemorrhagic granulation tissue struc-
ture is beautifully illustrated in early efforts at repair in fractures in 
bone. These facts, Barrie believes, should have weight against a diagnosis. 
of neoplasm. 
Steward (86) critically attacks Barrie's theory and emphasizes 
that myeloid sarcoma {giant-cell tumor) is a specific tumor taking origin 
from the fibrous tissue framework of the bone, and characterized by the 
invariable presence of osteoclast-like giant cells in large numbers, the 
latter being an integral and essential pa.rt of the tumor, making it un-
necessary to assume that some foreign substance must be present to account 
:tor them. 
ETIOLOGY OF GIANT-CELL TUMOR 7. 
Strongly substantiated by results of special investigations are 
the opinions of Lubarsch (62) and Konjetzny (56). Years ago Lubarsch had 
pointed out that the new growths observed in the course of osteitis fibrosa 
are of purely inflammatory nature. On the side of histological preparations 
Konjetzny showed how an intermedullary hemorrhage calls forth a reactive 
proliferative process. The product of this proliferative of the bone-marrow 
which can be compared to granulation tissue, consists histologically of all 
the elements encountered in lesions known as giant-cell tumor. The clini-
cal course and the radiological findings are very closely related to those 
of giant-cell tumors. In the course of the natural life of this granulation 
tissue there is a stage of differentiation when fibrous tissue, osteoid, and 
sometimes osseous tissue takes the place of the hemorrhage after it has 
subsided, the blood clot organized, and all the foreign elements removed. 
Thus, Konjetzny concludes that the apparent tumor is merely a "chronic 
resorptive process.tt 
The opponents of the opinion that giant-cell tumors are true blasto-
m.ota emphasize the following points of the histology of giant-cell tumors 
as supporting their views: the absence of pleomorphism of the cellular 
elements and of hyperchromatism of the nuclei and the absence of exces~ of 
mitoses; the differentiation of the cellular stroma into dense fibrous tissue 
poor in cells; the uniformity in the size, shape, and chromatin content of 
the giant cell nuclei; the relation of the giant cells to extravasations, 
indicating their role in resorption; and the constant presence of old blood 
pigment. All these features are not inconsistent with the probabl.e inflamma-
tory nature of these lesions. It is generally conceded ho~ difficult it is 
to distinguish histologically between a new growth in osteitis fibrosa and 
,-_I 
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ETIOLOGY OF GIANT-CELL TUMOR 8. 
entirely independent lesions considered as giant-cell tumors. This fact 
alone is sutficient evidence to raise doubt as to the right by which giant-
cell tumor is occupying i.ts place in oncology. On the other hand, there is 
no sufficient evidence accumulated to support the contention that in all 
cases of giant-cell tumor the lesion is a process of inflammation and repair. 
The etiology of the typical giant-cell tumor is readily understood 
if one accepts the new-growths observed in the course of osteitis fibrosa 
cystica as giant-cell tumors. The main complex of osteitis fibrosa is the 
disappearance of haemotoblasts and fat cells from the bone-marrow with a 
subsequent overgrowth of the fibrous stroma and lymphoid elements. This is 
accompanied by a simultaneous resorption of bone and new formation of osteoid 
tissue, and this lead.a later in the course of years to fractures and de-
formities. Frequently, in the course of the disease, one encounters for-
mation of cysts. Hemorrhage into the cysts may lead to an overgrowth of 
masses, resembling granulation tissue, which may enlarge and finally be 
recognized as giant-cell tumors. The frequent history of an antecedent mild 
trauma in giant-cell tumors has led to the recognition of trauma as an im-
portant etiological factor~ 
Barrie (6) reports that in all of twenty~eight cases one could 
elicit a history of recent or ancient trauma. Geschickter and Copeland (39) 
on the grounds of embryologic observations show how trauma acts in produc-
ing the bone cyst and giant-cell tumor. They maintain that trauma, in 
disrupting the cortical blood supply produces an imbalance between osteo-
clastic proliferation in the medulla and relative compact bone in the cortex. 
This osteoclastic activity to be of clinical significance, must be engrafted 
upon a normal histogenic process. It must be superimposed upon osteoclastic 
ETIOLOGY OF GIANT-CELL TUMOR 
resorption of calcified cartilage in the metaphysis in young patients to 
cause a bone cyst, and upon a similar in the epiphysis in adults to produce 
a giant-cell tumor. That additional metabolic factors may enter into the 
production of this imbalance is shown by the analysis of multiple giant-
cell tumors and bone cysts and the studies on the serum calcium and phos-
phorus in parathyroid disturbances. The work of Jaffe has shown that in-
crease in parathyroid hormone alone does not produce true tumors of this 
type although giant-cell areas and osteitis fibrosa-like tissue may be 
formed in the bone in animals fed with an excess of this substance. It is 
apparent, however, from the studies recorded by Geschickter and Copeland 
(39) that the age of the patient, the site of the injury, the rate and 
extent of cartilagionous ossification at the end of the bone and the nature 
of the blood supply in the affected regions are the predominant factors in 
the development of bone cysts and giant-cell tumors. 
Much depends upon the individual concept of trauma. Hemorrhage 
into the bone-marrow may lead to cyst formation. Organization of the intra-
medullary hematoma with the appearance of the peculiar medullary granulation 
tissue and expansion of the bone will then form the giant-cell tumor. Very 
· slight traumatization is frequently sufficient for the appearance of medullary 
hematomata.. While it is usually thought that fractures are not the cause 
but merely a complication of giant-cell tumor and osteitis fibrosa, it is 
probable that fissure fractures or, better, infractions with the rupture of 
nu~ient vessels may lead to the formation of giant-cell tumor. 
GROSS PATHOLOGY 10. 
Kolodny (55) gives a most complete description of the anatomical 
consideration of giant-cell tumors. The gross anatomy of giant-cell tumors 
depends largely upon the destructive and productive processes of the in-
volved bone. The tumor tissue during its period of growth constantly de-
stroys the bone while the periosteum lays down an advancing shell of new 
bone, thus preventing the tumor mass from an early perforation of the bone 
and an involvement of the adjoining structures. It is due to a combination 
of these two opposing reactions. of the involved bone that the giant-cell 
tumor is an expansible but not infiltrative or invasive lesion encapsulated 
in a bone shell. Eating its way into the bone, the tumor tissue destroys 
the bone from within the medullary cavity, gradually expanding the old cor-
tex, while a few more or less thick bony trabeculae running in various 
directions line the cystically expanded bone shell simulating beans, 
supporting the whole struct:ure. It is this structure that causes the most 
characteristic "soap bubble" appearance in the roentgenogram. The invest-
ing capsule of the giant-cell tumor is furnished_ by the new formed bone 
shell and the periosteum. Ewing (35) shows that with the increasing growth 
of this reddish jelly-like tumor mass, the bony shell may eventually become 
thin and allow passage of the tumor tissue, but there is seldom any tendency 
toward invasion of the soft parts. Long after the bone shell is thus per-
forated, the periosteum still continues to envelop the tumor until a very 
advanced development of the tumor or a pathological fracture hastens the 
perforation of the periosteal capsule. This is in marked contrast to a 
malignant bone tumor where the perforation of the bone and the periosteum 
occurs very early. 
The articular cartilage is very resistant in giant-cell tumor as 
it is in osteogenic sarcoma. It is most unusual to see the articular 
GROSS PATHOLOGY ll. 
cartilage destroyed by tumor tissue even in the advanced stage. An actual 
direct involvement of the joint cavity by tumor tissue is even less frequent 
than in osteogenic sarcoma; it occurs in pathological fracture and in very 
advanced cases. However, Gross (41) reported that the cartilaginous surfaces 
of the joint may be reached and absorbed and the joint surfaces may collapse 
from simple absorption, but without infiltration. Indirect involvement of 
the joint ~~vity may occur by tumor tissue spreading along intra articular 
ligaments, or from bone to bone along ligamentous attachments. 
The gross appearanc~ of the giant-cell tumor depends greatly upon 
the phase of the lesion. The typical giant-cell tumor consists of solid 
portions and numerous small cysts. The solid portions are very friable, 
crumbly, somewhat granular masses, varying in color from yellow and light 
brown to dark red. On incision, the tumor tends to extrude like granulation 
tissue. The texture of the growth becomes more. dense with the approximation 
to the periphery and capsule. This vascular, soft, readily oozing, and 
frequently profusely bleeding tumor, resembling currant jelly, is entirely 
confined within the bone shell, it lies there loosely and can be easily 
scooped out by a curette. With the aging of the tumor or after radiation. 
therapy, the tumor mass enters a cicatrizing phase. The reddish jelly-like 
tumor mass changes gradually, beginni.rig at the periphery, to a more opaque 
and firm mass, while in the central portion the old juicy stroma prevails. 
Some varieties of giant-cell tumors may be solid and firm throughout from 
the commencement and because of their frequent peculiar yellow color due to 
the presence of lipoid material, they have been designated as anthomata. 
The various phases of giant-cell tumor are a result of advanced differen-
tiation of the soft immature tumor tissue. All successive processes of 
repair can be traced here. 
GROSS PATHOLOGY 12. 
An attempt has been made to differentiate several varieties of 
giant-cell tumors which differ from the typical tumor grossly as well as 
histologically. Xanthoma is designated a variant of giant-cell tumor in 
which the presence of considerable fatty detritus lends the tumor a yellow 
appearance. Ewing (35) believes that the tumor may exhibit the features 
of a myxoma or myxosarcoma, being more or less translucent and elastic. 
It seems probable that the so-called m:yxomas of the marrow cavity have 
mainly this origin (57). The white giant-cell tumor is a rare but well 
I 
recognized variation. Stewart (87) reports a case and in his discussion 
states the sarcoma of bone , which are white in color, are almost invariably 
highly malignant. He, regards the maroon color as a secondary, even acci-
dental characteristic , due partly to increased vasculari ty and partly -
and more especially - to extravasation of blood. 
While practically all the modern descriptions of myeloid sarcoma 
insist on the constancy of this color characteristic, and only admit at most 
that portions of the tumor may be white, Sir James Paget (73) in 1853 states 
quite unequivocally that "the tumor may be all pale - .... - "· His descrip-
tion reads: "On section, the cut surfaces appear smooth, uniform, compact, 
shining succulent, with a yellowish, not creamy fluid. A peculiar appear-
ance is commonly given to these tumors by the cut surface presenting blotches 
of dark or 11 vid crimson, or of a brownish or a brighter blood colour, or of 
a pale pink, or of all these tints mingled, on the greyish-white or greenish 
colour basis. The tumour may be all pa.le, or have only a few points of 
ruddy blotching, or the cut surface may be nearly all suffused, or even the 
whole substance may have a dull modena or crimson tinge, like the ruddy 
colour of a heart or that of the parenchyma of the spleen." 
GROSS PATHOLOGY 13. 
Giant-cell tumors in whose texture islands of cartilage are en-
countered, are said to arise from absorption of misplaced islands of carti-
lage, when the released cartilage cells acquire a neoplastic character. 
When the vascularity of the tumor is not confined to the central portion, 
but is present in the largest partion of the tumor, it then represents the 
telangiectatic variety of giant-cell tumor. The clinical importance of 
such a differentiation of variants of giant-cell tumor is questionable, since 
there is no sufficient evidence accumulated to support the contention that 
these variants differ greatly in their clinical course. Furthermore, such 
variants cannot be distinguished before the tumor is submitted for a patho-
logical examination, gross or histological. The appearance of cysts in an 
.-... advanced giant-cell tumor is not uncommon. This also occurs after radiation r -, 
therapy, where in the central portion extensive necrosis and cyst formation 
filled with blood clot and serous fluid occurs. 
The cysts are filled with blood or chocolate-colored fluid, or 
an opaque, brownish, or greenish mucinous mass, a greenish or grayish serum, 
evidently the product of various stages of decomposition of blood extra-
vasations. 
.,,-.... 
MICROSCOPIC ANATOMY 14. 
Kolodny (55) reports that the histological structure of the typical 
giant-cell tumor cohsists of two leading elements: the giant-cells, and the 
stroma. The latter consists of numerous various sized blood spaces and 
exceedingly thin walled capillaries suspended in a very loosely woven net 
of spindle, round or polygonal cells with large vesicular nuclei. One of 
the most characteristic features of a giant-cell tumor is the absence of 
pleomorphism of the cells of the stroma.. Geschickter and Copeland (39) re-
port that the round cells outnumber the spindle cells in every instance in 
this typical tumor. This small round cell has a relatively large nucleus 
and a small amount of cytoplasm. There is a definite nuclear wall and a 
nucleolus. There is, apparently, a definite relationship between the round 
cell of the stroma and the giant cell. In the first place, when the giant-
cells predominate in the tumor the round cell prevails in the stroma. More-
over, the nuclei of the giant cell always have the same general form and 
staining characteristics as the nuclei of the round cells. The only impor-
tant variation is the tendency for the giant cells to have a more acidoph-
ilic cytoplasm with occasionally a greater concentration of chromatin in the 
nuclei and other signs of early degeneration. This could be accounted for 
by the age of the giant cell, the inference being that the giant cells are 
formed by agglutination of the round cells in the stroma (~) 
In the central portion of the tumor, fresh extravasations of blood 
as well as hemosiderin can be found near the periphery of the bone shell. 
Geschickter and Copeland (39) also report that red blood cells in a well 
preserved state are scattered through the tumor more often unenc~osed than 
enclosed by endothelial walls. The typical giant-cell tumor is thus both 
MICROSCOPIC ANATOMY 
hemorrhagic and vascular, newly formed vessels being by no means rare. 
Areas of organizing hemorrhage are frequent, and bordering on these is 
loose edematous t~ssue intermingled with areas like those of osteitis fibrosa. 
The giant cells average over 30 per field under the low power, with the number 
of nuclei in each cell varying from fifteen to two hundred. The cells range 
in size from ten to one hundred microns and may or may not have distinct 
borders to the cytoplasm. Kolodny (55) states that the histogenesis of this 
peculiar cell is still a subject of discussion; the theory in vogue at pres-
ent is that these cells originate from the endothelium. Barrie and his 
associates (2,3,4,6,42) regard giant-cell tumors as a chronic, hemorrhagic, 
non-suppurative osteomyelitis, probably of traumatic origin and consider that 
the histological structure is indistinguishable from that of granulation 
tissue and that the giant cells, of endothelial origin, are scavengers formed 
for the purpose of absorbing and removing the detritus resulting from bone 
destruction. 
According to Mallory, there are two types of giant·cells, a tumor 
giant-cell and a foreign body giant-cell. The former are large, clear, 
bladder-like cells, with distinct outline but staining faintly, within which 
are multiple nuclei, which stain dreply and are situated in the center of 
the cell. They are true tumor cells resulting from multiple mitosis and 
signify rapid growth. The second type are as a rule smaller, their cyto-
plasm fairly abundant, sharply defined and staining deeply with acid dyes. 
The nuclei are smaller, uniform, without mitosis, and are often in clusters 
near the periphery of the cell. They resemble osteoclasts and are merely 
a reaction to the presence of foreign bodies and are due to the fusion of 
endothelial leucocytes. 
l""" 
MICROSCOPIC ANATOMY 16. 
Stewart {86) agrees with Schafer (82) that the specialized fibrous 
tissue framework also provides the multi nucleated osteoclasts, whose func-
tion is bon~ absorption, and that they probably represent a specific form 
of giant-cell. Goforth (40) believes that two mesoblastic tissues, the 
osteoblastic or osseous tissue proper, and the fibroblastic, or specialized 
fibrous tissue framework intimately associated in bone structure, are the 
elements composing giant-cell tumor. Carnegie Dickson (31) and others, 
think it probably arises from the reticulum of the marrow. Kolliker (54) 
and Gross (41) believe it originates from the osteoblast. Jordan (50) who 
has made a very careful study of this subject believes it may arise in either 
of the last two ways. 
lo conclusive work has been universally accepted as to whether the 
giant cell is an integral part of the tumor, or as Barrie (3) believes, a 
cell attracted to the tumor to remove the numerous particles present, due 
to extensive disintegration. Whatever opinion one may hold, one cannot deny 
that the structure of a typical giant-cell tumor with the abundant giant 
cells tied up like knots at the junctions of the endothelial strands suggests 
that the giant cells play an important role in the composition of the tumor. 
It is true that, when needed, the giant cells take up the function of scaven-
gers and it is not uncommon to find, in giant cells, fatty detritus, remnants 
of blood cells, blood pigment, and even small spicules of bone. 
Geschickter and Copeland (39) are of the opinion that giant cells 
with few nuclei, relatively small and sparsely distributed, are not typical 
of the benign giant-cell tumor, but are more characteristic of osteitis 
fibrosa and osteogenic sarcoma. 
MICROSCOPIC ANATOMY 17. 
Ewing (34), in describing the giant-cell tumor and its variants, 
emphasized that a study of the stroma offers a standard for differentiating 
between giant-cell tumor and medullary osteogenic sarcoma, secondarily con-
taining giant cells, and is inclined to restrict the importance of the giant 
cells themselves. 
Spicules of bone, some undergoing destruction and others represent-
ing a healing reaction, are frequently found near the margin of the tumor or 
its capsule. Kolodny (55) believes that to avoid errors in diagnosing a 
giant-cell tumor from the histology, one has to keep in mind the various 
deviations. from the typical giant-cell tumor structure. In the so-called 
xanthoma, the resorption of a considerable amount of fatty detritus leads 
to an impregnation of the phagocytozing cellular elements with lipoids. 
Typical giant cells are few here, and their place is taken by aggregates of 
endothelial leucocytes which are peculiar here because of the fairly granu-
lar cytoplasm resulting from the lipoid inclusions. These are the so-called 
"foam cells". In the myxomatous type, the peripheral portion consists of 
spindle cells, with a large chromatin content of the nuclei, embedded in a 
mucinous mass. 
The type of giant-cell tumor originating in connection with an 
absorption of misplaced islands of cartilage, presents a marked deviation 
from the normal structure. Numerous imperfect cartilage cells are seen and 
are called "epithelioid cells", because of their resemblance to epithelial 
cells. Unlike malignant bone tumors, in which the destruction of the in-
volved bone is accomplished by both osteoclasts and tumor cells, in giant-
cell tumors the task of destruction of the cortex is taken ove:r~.by- giant cells. 
MICROSCOPIC ANATOMY 18. 
When a recurrence bas taken place in a giant-cell tumor, the his-
tology shows a variable picture and is always of an altered character. 
Cicatrization of a giant-cell tumor may be hastened occasionally by incom-
plete curretage and sometimes even by an exploratory incision, provided in-
faction does not set in. Frequently, however, infection is not avoided and 
the infected fungating pulsating masses of the tumor acquire an appearance 
of a malignant new growth. Histologically, such a giant-cell tumor is 
greatly changed by the admixture of a reaction to infection and by stimula-
tion to active grawth. 
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The clinical incidence of giant-cell tumors is apparently lower than 
that of primary JD&lignant bone tum.ors. According to the report of Cod.man (21) 
from the •terial or the Registry of Bone Sarcoma, the relative frequency or 
giant-cell tumors as compared with malignant bone tumors is about 1:2. 
Kolodny (55) believes this ratio is probably an exaggeration of the frequency 
of giant-cell tumors, since the Registry material counts any eases in which 
the patients were alive at the time the Registry began, while the average life 
duration of a patient with a malignant bone tumor is about twenty months. The 
giant-cell tum.or is more frequently met with in the female than in 1he male; 
the ratio 6:5 is probably a fair expression of this frequency. Kolodny (55) 
believes it is in the decade between sixteen and twenty-five that most giant-
cell tumors occur, an age considerably higher than for osteogenic sarcoma and 
Ewing's sarcoma. In 28% of females the disease occurred after the age of 
thirty, as against 41% in males. The youngest patient was a girl of six, and 
the oldest ~ man of sixty-eight. Platt (80) reports that over half or the 
cases in his series have been patients in the fourth or even fifth decade of 
life. Dindeedn, he writes, Uthe Surprising incidence Of this tumor in the 
middle aged occasionally leads to difficulties in the differential diagnosis 
of solitary secondary malignant tumors of the long bones, where the primary 
growth is laterit. Geschickter and Copeland (39) report·tbat'forty per cent 
of all cases are in the third de~ade of life. 
Peirce (76) reporting the incidence of giant-cell tumors in the 
last eight years from the University of Michigan, excluding involvement of 
either maxilla or mandible, gives the age variation from four to forty-nine. 
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There were two in the first decade, eight in the second, four in the third, 
three in the fourth, and two in the fifth. Of the nineteen cases, eleven were 
male, eight femle. 
The location of the giant-cell tumor is in marked contrast to that 
of osteogenic sarcoma as far as the bone and the site of involvement is con-
cerned. The bones of the lower extremity were involved in 56% of all cases 
of the Registry (21), While those of the upper extremity were involved in 23% 
of all cases; in 21% of all cases the bones of the trunk, including the pelvis 
and the shoulder girdle and the jaws, were involved. or all the cases of 
involvement of the upper extremity, the radius was involved in 40%, all in 
the lower end or the bone. The femur was involved in 57% of all cases of 
giant-cell tumor of the lower extremity and the tibia in 36%. The lower end 
of the femur was, as a rule, in vol v'd, with very few exceptions, when the 
tumor was situated in the upper third of the femur about the troehanters. 
The lower end of the femur is involved mu.ch more frequentl7 in the mle than 
in the female, while an involvement of the upper end of the tibia, which is 
three times as freqmnt as that of the lower end of this bone, is seen more 
frequently in women than in men. In general, in about 47% giant-cell tumors 
were situated in the lower end of the femur and.the upper ~nd of the tibia. 
The jaws were the seat of the tumor in about 9% of all cases, the spine follow-
ing closel7 with 8% ot all cases of involvement. Involvement of the jaws, 
which is eqully distributed between the upper and lower jaw, is apparently 
rare a£ter the age of 25. The shaft of the long bones was involved in two 
cases, while in both these cases there was place for doubt as to the accuracy 
of the diagnosis, since a cyst complicated by a fracture could not be ruled 
out. Giant-cell tumor is situated in the smll bones ot the extremities more 
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frequently than osteogenic sarcoma. In contra,at with osteogenic sarcoma, in 
which the epipbysis frequently escapes involvement because .or the epiphyseal 
cartilage serving as a barrier to the spreading tumor, in giant-cell tumor the 
epiphysis is involved in a large majority or cases. Here the epipbyseal carti-
lage does not seem to exert any influence upon the spreading of the tumor and 
the latter frequently extends from here into the diaphysis. As a rule the 
giant-cell tumor appears as a solitary lesion, and it would seem probable that 
in some of the cases of multiple giant-cell tumors, one is dealing with a 
proliferative osteitis fibrosa. 
Alexander and Crawford (1), Kanavel (51), llartland and Haussling (42) 
and Barrie (5) have reported what they have believed to be multiple giant-cell 
tumors of bone. In a recent communication from Crowell to Alexander and 
Crawford (l) five additional cases are given which were presented to the 
Registry of Bone Sarcoma. It is interesting to note that no cases of multiple 
giant-cell tumors have been accepted as true entities by the Committee on Bone 
Sarcoma. Codma.n, in communication with Alexander and Crawford (1) states that 
he is skeptical about the existence of the condition. Giant-cell tumors have 
been found in almost every bone in the body. 
Geschickter and Copeland (39) report from the records of the surgical 
pathologic laboratory of the Johns Hopkins Hospital for a period of over thirty-
five years, only twenty-two cases of giant-cell tumor occurring in the head, 
excluding the epulis of the alveolar border. Two of the giant-cell tumors were 
found in the temporal fossa, six are recorded in the upper, and fourteen in 
the lower jaw. All of these have been fomd in sites of bone formed from car-
tilage and none from the purely membranous portion of the calvarium (the 
frontal and parietal bones). Dean Lewis (60) in 1924 reported a case of primary 
giant-cell tUJDOr of the vertebrae and reviewed sixteen cases from the literature. 
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Cotton (27) in 1928 reported a similar case. Kraft (57) described a 
case or giant-cell tuaor or the patella and lie.thews (67), one of the clavicle. 
The giant-cell.epulis of the jaws is quite frequently met with. It is outside 
of the scope or this paper to deal with them specifically and the reader is 
referred to· excellent discussions by Geshickter and Copeland (39), Bloodgood 
(11) and Scudder (83) for more detailed information regarding them. 
Beekman (8), Broders (17), Garrett (37), and Ila.son and Woolston (66) 
have recently reported cases or giant-cell tUJllors or the tendon sheath, and 
emphasize the propensity for these tumors to occur on the hand about the 
~ingers, and on the foot and about the ankle. Geschickter and Copeland (39) 
.. 
support the view that the giant-cell tumor of the tendon sheaths arise in 
the sesamoid bones. 
The usual clinical history given by these patients has a sequence 
of trauma, pain, tumor and fracture extending over a period of from two to 
fourteen months. Pain in these cases is usually more severe than in bone . 
cysts, but of less severity than in osteogenic sarco•, of a more constant 
nature, and is sufficient to cause disability. 
Pain is frequent and early complained or by a patient afflicted 
with giant-cell tumor. The pain, however, is of less severity than in osteo-
genic sarco•, and it is more persistent after radiation therapy is begun. 
The patient's general condition usually remains good unless an exploration 
or incomplete curettage was done, accompanied by infection. Infection is 
very persistent in giant-cell tumor, and it may lead to sepsis in a brief 
period of time. The skin frequently lacks the dilated veins commonly seen 
in osteogenic sarcoma. When the skin is very distended by the large tumor, 
it ma:y resemble pig skin, be edematous and cyanotic. Ulceration or the skin 
,,,,,.... ' 
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occurs apparently only in the very far advanced cases which have long gone 
without medical attention. In the chapter on diagnosis I have discussed more 
completely the physical_findings. 
As a rule, giant-cell tumor is of long duration and slow growth; 
notable exceptions are known, however. At the present day, advanced stages 
of giant-cell tumors are seldom seen since their growth is interrupted by 
surgery or radiation. Occasionally, in long standing tumors, attempts at 
spontaneous healing occur, - cicatrization with ossification of the peripheric 
portion and cyst formation in the center. When infection takes place fatal 
hemorrhage and sepsis may ensue. After breaking through the investing cap-
sule, the tumor travels along the intermuscular and fascial planes but does 
not inve.de the muscle tissue. Orthopedic problems arise from tumors of the 
spine. Infraction is almost a rule in giant-cell tumor, especially in the 
weight-bearing bo~es, where also complete pathological fractures are frequent. 
Geschickter and Copeland (39) report that pathologic fracture occurs in about 
14% of these cases, or about one third as often as in the bone cysts. This 
fact again emphasizes the necessity of splintering and recumbency. The 
pathological fracture of the lower extremity is usually of the telescoping 
variety, with one end of the bone projecting into the cystically dilated 
other end. Joint involvement is exceedingly rare •. 
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While some experienced observers maintain that it is always possible 
to arri~e at a diagnosis in giant-cell tumor from a microscopic examination 
of the section alone, and others claim that the clinical history together with 
the physical findings and roentgen-ray features will suffice for diagnosis 
without an exploration of the tumor. Kolodny (55) believes that there are 
times when neither method of examination, clinical and radiological, or mi-
croscopic, nor both of them combined will suffice for an accurate diagnosis. 
These cases are rare, frequently they are complicated by previous surgical 
treatment. These are the cases referred to by Ewing (34) as the "borderline" 
giant-cell tumors, with a wide destruction of bone, with an absence of bone 
shell, with smaller than usual giant cells contaµ.ing larger and more hyper-
chromatic nuclei; they present a difficult task for the pathologist, especially 
when diagnosis is requested from small curetted pieces of tissue. Kolodny 
(55) believes that to the careful observer a complete history and thorough 
physical examination, supplemented by satisfactory roentgenograms, will suf-
fice for an accurate diagnosis in the majority of cases. According to 
Kolodny (55) palpation is an important diagnostic aid in the examination of 
a giant-cell tumor. Frequently, one is able to palpate the bony capsule of 
the tumor and its bbrders at the junction with the uninvolved diaph.ysis. The 
.. 
bulky spheric shape feel of the tumor contrasts it from the fusj.form shape 
of the osteogenic sarcoma. It is much easier to palpate in giant-cell tumors 
because of relative absence of tenderness. When the bone shell of the tumor 
becomes very thin, egg-shell crackling can be made out. In the very vascular 
variety of giant-cell tumors one occasionally feels a bruit. 
Herendeen (44) believes that the location of the tumor is one of the 
most important points in the diagnosis of giant-cell tumors. Although they 
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may occur in any-bone in the body (they have been found in the skull, 
vertebrae, ribs, pelvis, upper end of femur and humerus, lower end of the 
ulna and radius, tibia and fibula), the most common sites are in the ends 
o; the bones at the knee joints, and a tumor in the medullary portion of the 
distal end of the radium is nine times out of ten a giant-cell tumor. Giant-
cell tumors may occur in the shaft or at some distance away from the end of ·· , 
the bone, but in these instances the diagnosis is more uncertain and the 
chances are greater that the tumor is a malignant one, as purely benign pro-
ceases, other than giant-cell tumors such as chondromas and cysts in the 
medulla of bones are comparatively rare. 
Morton and Duffy (69) of Yale University :Medical School published an 
article on Bone Sarcoma in which they stated: "We are impressed with the 
difficulties which confront the average surgeon in arriving at a correct 
diagnosis and in deciding on proper treatment in any group of bone tumors. 
There are so many exceptions to the rule, that each case must be most com-
pletely studied and weighed before action is taken. Were we to trust to the 
Rontgen-ray picture for diagnosis we would in many instances be wrong. Were 
-
we to depend upon the microscopic se~tions alone, especially at the time of 
operation, we would be often misled. " 
Robert Osgood and his collaborators (72), in an editorial note follow-
ing a review of Tumors of Bones, say : "Differential diagnosis of bone 
tumors is far from certain by any known method, particularly rontgenoscopy. 
This is altogether natural when we remember that even with the gross specimen 
before him and the slide under the microscope, the pathologist is often un-
~ certain as to its character. Often there is such widespread involvement of 
the bone that it is impossible to determine the point of origin or the in-
vasion. While in sympathy with any effort to systematize the diagnosis, we 
are under the impression that the one point of importance is whether the 
'\' 
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growth is benign or malignant, and that the best way to determine this is by 
immediate exploration and pathologic examination. The relation of the region 
to be examined is also of importance, and occasionally the surgeon well trained 
in gross appearances in malignant disease must be governed by his finding quite 
as much as by the report of the pathologist, made necessarily somewhat incom-
pletely at the time of operation." 
Bost (16), in an excellent article on differential diagnosis, writes 
that giant-cell tumor must be differentiated from the following single osteo-
lytic bone tumors: (1) bone cyst, {2) osteolytic sarcoma, (3) Brodie's 
abscess, (4) chondroma, {5) latent bone cyst, (6) sihgle metastatic tumors, 
and (7) osteitis fibrosa cystica. It must also be differentiated from latent 
osteomyelitis and tuberculosis. Bone cysts involve mainly the diaphyses of 
the long bones and occur in the early epiphyseal age, from 5 to 15 years of 
age, and most often in the upper humerus, lower tibia, and upper femur. This 
t~mor expands the bone only slightly. The cortex of the bone at both ends 
of the cyst is thinned out so that there is a gradual thinning of the cortex 
from the middle of the cyst to the poles, and not the abrupt transition of 
the normal cortex frequently seen in giant-cell tumor. 
Osteolytic sarcoma is a malignant tumor occurring in patients from 
10 to 20 years of age and involving the upper tibia, lower femur, and upper 
humerus. The point of differential diagnosis in this tumor is the fact that 
the tumor is medullary and rapidly destroys the cortex without expansion. 
This differentiates these tumors from benign lesions. 
Brodies abscess may rese~ble a giant-cell tumor, but as a rule this 
condition involves the shaft of a long bone with no expansion or destruction 
of the cortex. 
.-
-
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Chondroma may resemble a giant-cell tumor. However, these growths 
usually occur in the phalanges of the hands and feet, and in the sternum, 
where the giant~cell tumors rarely occur. 
Latent bone cyst originates at any age, and is usually discovered 
aecidentaly in the third decade. This cystic disease differs very little 
from the usual bone cyst, except that the condition has existed from child-
hood, being in a quiescent state without extension of the process. 
Metastatic carcinoma to bone should rarely be confused with giant-
cell tumor. It usually occurs in the bone near the nutrient artery, the mid-
portion of the bone. The cortex is entirely destroyed without any evidence 
of its expansion. Metastatic carcinoma occurs usually after the age of 40, 
and more frequently in females. The disease is rare in bones below the elbows 
or the knees. 
The benign giant-cell tumor may at times simulate a la.tent osteomye-
li tis. In these cases, a complete clinical history is of greatest value, and 
should always be secured in cases of doubtful diagnosis. 
Tuberculosis gives a fairly definite clinical history. Joint involve-
ment with subsequent disability is always an early feature, whereas in giant-
cell tumor the joint is not usually involved. ~ben this does occur, it is 
always late in the history of the case. The distinguishing factor is that in 
giant-cell tumor the enlargement is asymmetrical, whereas in tuberculosis there 
is symmetrical enlargement. 
Osteitis fibrosa cystica with bone destruction and thinning of the 
cortex often resembles giant-cell tumor. However, in oste~tis fibrosa cystica 
_ we find no expansion of the cortex, so typical of giant-cell tumor. Giant-
cell tumor involves the epiphysis after ossification, while osteitis fibrosa 
cystica is present in the shaft of the bone before ossifica~ion. 
·-
-
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Early osteogenic sarcoma may at times be difficult to distinguish from 
giant-cell tumor. However, giant cell tumor is always present in the epiphy-
seal area of the bone. New bone is produced in osteogenic sarcoma and is laid 
down in radiating lines perpendicular to the shaft, whereas new bone is never 
produced in giant-cell tumor. 
Radiological examination is of outstanding diagnostic importance. 
Repeated radiological examination of skeletal tumors from many angles is in-
dispensable for an accurate diagnosis. The roentgenogram is frequently of 
more importance than a microscopic examination when a variant of giant-cell 
tumor is dealt with. 
The radiological appearance of a giant-cell tumor is most character-
istic. It usually casts a bulky spherical shadow, showing a_multicystic 
appearance as a result of the osseous trabeculation in the periphery. The 
shaft of the bone is absent and it appears as if the cortex is blown out from 
within the medullary cavity so as to form the thin bone shell, which sharply 
limits the tumor from the surrounding soft tissues. A continuation of the 
bone shell is seen limiting the tumor from the adjoining unaffected medullary 
cavity. When in advanced cases of giant-cell tumor, the bone shell is de-
stroyed, in some areas the roentgenogram will simulate an invasion of the 
tumor into the soft tissues in spite of the intact periosteum. This should 
not confuse the reader from diagnosing giant-cell tumor. When the adjoining 
periosteum and cortex remain unaffected, this points strongly against osteo-
genic sarcoma. The shaft is absent in giant-cell tumor, but may be seen 
running through the osteogenic sarcoma. In giant-cell tumor, the tumor is 
in direct contact with the articular cartilage, while in osteogenic sarcoma a 
thin layer of spongiosa remains between the tumor and the cartilage. 
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Nichols (71) in an endeavor to simplify the roentgenologic diagnosis 
of bone tumors suggests a differential method based on the observation of four 
fundamental points: (1) their origin, whether medullary or cortical; (2) 
whether or not they are characterized by bone production, by bone destruction, 
or both; (3) the resultant condition of the cortex, whether expanded or de-
stroyed, and (4) whether the growth is invasive or non-invasive. 
When combined with the clinical history, physical findings and radio-
logical features, the data of a pathological examination are of valuable 
diagnostic importance. To one experienced in the pathology of bone tumors, 
the gross anatomy of a giant-cell tumor will frequently mean more than the 
histology. It is well to remember that an occasional tumor can resemble 
grossly or histologically a giant-cell tumor and not be one, The histology is 
frequently misleading in giant-cell tumor, especfally so when e frozen section 
is relied upon, as often happens. The diagnosis of giant-cell tumor from the 
section must not be based upon the presence of giant-cells alone; the type of 
supporting tissue is most important, although the giant cells are said to be 
an integral part of the giant-cell tumor they are occasionally encountered 
also in typical osteogenic sarcoma where lime salts are set free by rapid 
erosion and disintegration of bone. The very vascular, so-called telangiec-
tatic osteogenic sarcoma may resemble grossly vascular giant-cell tumor. The 
histology is often misleading in the variants of giant-cell tumor. In the 
rnyxomatous variation the histology may suggest malignancy while the clinical 
findings e.nd radiological features clearly indicate the benign nature of the 
lesion. In cartilaginous giant-cell tumors in a few cases a diagnosis of 
.- myelome. has been returned by the pathologist because of the abundance of 
rounded cells of the stroma. Occasionally several varibnts may be found in 
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the same tumor. The histology is especia.lly deceiving when the tissues are 
taken from tumor masses fungating through a former exploratory incision. 
Shall a biopsy be performed before any method of treatment is adopted? 
Upon this point there is the widest variance of opinion. It wuuld seem that 
the whole question is merely a part of the general advisability of a biopsy 
in bone tumors of doubtful nature, since the necessity of exploration indicates 
that one is not certain whether the tumor is benign or malignant. The diffi-
culties encountered in a diagnosis from the histology in a doubtful giant-cell 
tumor are great to those little initiated in the pathology of bone tumors. 
Ewing (34) repeatedly stresses the importance or desirability of making a 
diagnosis without biopsy. Kolodny (55) P.elieves that as a general rule, when 
the clinical findings and the roentgenogram are barfling to the clinician, 
the histology is also distressing to the pathologist. Whatever one may say 
about the increase of malignancy in giant-cell tumors, by an exploratory 
incision, one cannot deny that the dangers of infection with which such ex-
plorations are entailed are very great. However, if a biopsy is done, the 
curettage of the tumor should be completed because a following infection will 
add greatly, to the difficulties of radiation. 
Bloodgood (14) suggests the following working rule for the diagnosis 
and treatment of tumors of bone. If a patient is under ·fifteen years, it is 
probable that sarcoma is not present, and the diagnosis rests between the 
common bone cyst, the less frequent giant-cell tumor and the rare chondro-
my:xoma. If the patient is over fifteen, sarcoma cannot be excluded. The 
most common central lesion of bone is the benign bone cyst. In the majority r:f 
cases, they recover without any treatment. The second is the giant-cell tumor, 
which predominates in patients over fifteen. Myxoma may occur at any age. 
I~ 
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Myxoma must be constantly borne in mind, and is the most difficult of all bone 
tumors to eradicate locally. 
The location of the tumor is also important: whether in the end of the 
bone, in the joint, or in the middle of the bone near the nutrient foramen; 
the last being the favorite site of the metastasizing carcinoma. Malignant 
tumors do not cross a joint, so that a lesion involving both sides of the joint 
is always a benign process. Whether the tumor is single or multiple, is also 
important, as is also the age of the patient. 
Geschickter and Copeland (39) are of the opinion that the adult age 
of the patient and the involvement of an epiphysis are the most important aids 
in making a differential diagnosis. The other common central bone destructive 
lesion occurring in an adult is a single focus of metastatic carcinoma. 
Bost (16) believes that giant-cell tumor may often be positively diag-
nosed by the roentgen findings, but not always. He presents the following 
characteristics of giant-cell tumors from the roentgenologic standpoint: 
(1) the lesion is subcortical, beginning at one side of the epiphysis and 
gradually extending centrally, involving cancellous bone; (2) the lesion is 
almost always invariably single; (3) it is an epiphyseal disease, the lesions 
involving most frequently the upper end of the tibia, lower femur, and lower 
radius; (4) the tumor occurs usually between the ages of twenty and thirty 
years; (5) the tumor appears in the roentgenogram as a circumscribed bone de-
structive lesion, involving the epiphysis and diaphysis, the tumor being 
globular, trabeculated, and asymmetrical; (6) the growth is medullary, and of 
osteolytic character; (7) giant-cell tumor arises only in bone derived from 
~ cartilage, a fact which gives these tumors their characteristic location and 
age distribution. 
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Barrie (6) presents the following table covering the more important 
features pertaining to the solitary lesion in making a diagnosis of hemorr-
• 
hagic osteomyelitis {giant-cell tumor): 
Clinical Picture 
Age of Patient - May occur at any age. Most frequent in first and 
second decades of life. 
Duration of Lesion - Months - perhaps years before lesion attains 
large size. 
Symptoms of Onset - Usually history of injury, recent or remote. 
Pain - - Apparently never constant. 
Inspection - Usually some enlargement of site of lesion. 
Palpation - - Tenderness and pain on pressure. 
Joint movements Some limitation of motion in nearest joint. Limp 
with lesion in lower extremity. 
X-RAY PATHOLOGY 
Cancelli - - Area of osteolysis rather clear cut, rounded or 
oval in shape. 
Periosteum - - Usually intact unless lesion has attained large 
size, years after onset. 
Gross Pathology Appearance of vascular granulation tissue sometimes 
interspersed with areas of fibrosis, or degenerated 
hyaline masses. 
Microscopic Picture - Heterogeneous cellular picture of fibroblasts, 
scavenger giant-cells, endothelial and polynuclear 
leucocytes, lymphocytes, eosinophiles and red blood 
cells. 
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The theory that giant-cell sarcoma is always a benign lesion and 
never metastasizes dates back to the middle of the nineteenth century. In 
1854 Sir James Paget (74), in his lecture on surgical pathology, gave Lebert 
full credit ror being the first one to describe giant-cell tumors. After a 
stug.y of Lebert' s cases, as well as a few of his own, Paget very modestly 
concludes that his own observations are too rew and too various to warrant 
many general conclusions. Those which he tentatively expressed, however, 
were: 
"The tumor is single, occurs most frequently ih youth, rarely in adult 
age, is slow in growth, and without pain, and generally comes on without 
any known cause such as injury; has no tendency to ulcerate. - - - They 
"47 (but I suppose very rarely) cease to grow. They are not apt to recur 
after complete removal, nor have they in general any features of malignant 
disease." 
And then, at the end, Paget very wisely adds, that while these and many other 
cases may be enough to prove that the myeloid tumors (giant-cell tumors) are 
generally of an innocent nature, "still, I suppose, cases may be found in 
which, with the same apparent structure, a malignant course is run." Further 
observations have shown some of Paget's conclusions to be incorrect. It is 
now known that injury is a very important factor as an exciting cause. 
Coley (24) reports that fifty-six per cent of his series of cases gives a 
distinct history of antecedent local injury, and also that pain is one of 
the earliest and most constant symptom. 
Nelaton, in 1860, strongly advocated the view that giant-cell tumors 
are only locally malignant, and furnishing much new data in support of this 
view. 
,..... 
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Bloodgood (10,12,13) for Jl8DY' years has upheld this doctrine and at 
present the majority of pathologists here and in Europe have accepted it. 
Coley (24) states that, "This view has been expressed so often and so em-
phatically that Jll8JlT surgeons have accepted. it without a sufficiently care-
tul or critical examination of the data upon which it is founded." Only in 
the light of data accumulated from the clinical history, physical and radio-
- logical findings and pathological exa•ination may a prognosis be given. 
When left alone, the giant-cell tumor may follow one of two wa7s. 
_ Advanced growth of the tumor may lead to fatal he•orrhage or septicemia. 
Occasionall7, following a pathological fracture, slJC)l a tumor may enter a 
cicatrizing stage. The bony- shell may become very thick. 
The question of the prognosis of giant-cell tumor treated conserv• 
tively by curettage or radiation, for.a a subject for ardent discussion. 
On one side many cases are cited of giant-cell tumor leading to pulmonary 
metastases, and death. Kolodny (55) reveals two sources of error of these 
authors by a careful study of their cases. The first is that not in all 
cases mentioned was the primary- lesion a giant-cell tumor, and the second 
that not in all fatal cases are metastases proved to have been present. On 
the other hand, the authors believe that giant-cell tumors are always benign 
lesions lacking the ability to produce metastases. The exceedingly few cases 
of giant-cell tumor in which, after repeated surgical operations, pulmon&r7 
me~stases and death occurred these authors explain by the fact that due to 
surgical insult and ill-advised therapeutic measures the giant-cell tumor 
becomes transfor.ed into a malignant bone tumor which, as a malignant tumor 
and not as a giant-cell tumor, led to pulmonary metastases. 
Gross (41} in 1879, for the first time, reported five cases of be-
nign giant-cell tumors which underwent degeneration. From this time on, 
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the question of benignity.or malignancy of the giant-cell tumor led to some 
of the most passionate disputes ever known in medical literature. Thus, 
while Bryant (18), Bloodgood (13, 15), Martland (65), Stone and Ewing (89) 
Codman (20) and Meyerding (68) and others, considered the benign character 
of the lesion as unquestionable, Stewart ( 88) , Waugh and Turner ( 90) , 
Shattock (84), MacGuire and McWhorter (63), Finch and Gleave (36), King (52) 
and especially Coley (24) repeatedly emphasized that some of the giant-cell 
tumors are distinctly malignant and that they produce metastases. Not even 
the Registry could settle the question definitely. While Codman (20) is 
"convinced that they are benign", Kolodny (55) after analyzing the same 
material says: 11The question as it stands today is whether or not a giant-
cell tumor is always benign. From the evidence on hand, this question is 
to be answered in the negative." At the same time Goforth (40) writes: 
"Giant-cell tumors constitute a series. Those at the lower end of the scale 
show relatively adult fibrous stromas·, and are essentially benign. They 
exhibit more cellular and active stromas, composed chiefly of relatively 
immature fibroblasts cells, and become increasingly more locally aggressive 
as the scale is ascended." 
Evans and Leucutia (33) believe the giant-cell tumor is essentially 
benign, but believe that such a differentiation as that of Goforth is of some 
help from the therapeutic standpoint. It is comprehensible that a rather 
cellular tumor with immature fibroblastic elements would show a great ten-
dency toward recurrence, especially if incompletely removed. Moreover, since 
with each recurrence, the tumor is apt to become more and more virulent, it 
~ is plausible that finally a malignant degeneration of the lesion should follow. 
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Stone and Ewing (89) described such a case. Evans and Leucutia (33) 
believe that the majority of eases described in the literature as primarily 
malignant giant-cell tumors are based on mistaken or incomplete diagnosies. 
Dr. Channing Simmons (85), in analyzing the cases of the Registry, concludes 
that there is no instance in which a proved giant-cell tumor formed metastases. 
He cites cases 295, 349 and 68 to show that the giant-cell tumor may change 
its character and become osteogenic sarcoma which metastasize in the usual 
manner and causes death. He states that giant-cell tumor is known to become 
an osteogenic sarcoma in about 3.7% of the cases. Crowell, (29) in present-
ing the 1933 report on the Registry of Bone Sarcoma, lists 272 cases of 
benign giant-cell tumor, and 14 cases of malignant giant-caµ tumor. 
The main factor in the clinical course of giant-cell tumor requiring 
one to be on guard in the prognosis is rapid growth of the tumor. The typical 
giant-cell tumor is of long duration and slow course. Rapidity of growth 
is a sign of aggressiveness of the tumor. Another reliable sign of aggress-
iveness is the destruction of a large portion of the bone shell of the tumor. 
A giant-cell tumor reaching a very large size is very apt to recur after 
curettage since the size of the tumor excludes the possibility of a complete 
removal of the tumor tissue. With each recurrence the prognosis becomes 
less favorable. Care should be exercised in the arrival at a prognosis based 
upon a recurrence, because with each recurrence the growth is apt to become 
more anaplastic and malignant. The high percentage of clinical recurrences 
after treatment in typical giant-cell tumor spaalts for the progressive nature 
of this disease. Geschickter and Copeland (38) reviewed 222 cases of giant-
cell tumor in the surgical pathological laboratory of Johns Hopkins Hospital 
and f o\Dld that there were thirty-one recurrent cases following a primary 
curettement, and many of these showed repeated recurrences despite surgical 
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intervention. Recurrence was found to depend not on histologic structure, 
but on a poor selection in the type of treatment applied in the individual 
case or on an incomplete operation. Advanced destruction of the bone shell, 
incomplete currettement, failure to use chemical or thermal cauterization 
or needless sacrifice of cortical bone at the operation. as well as an age 
QVer 35, were found to be factors predisposing to recurrence after curette-
ment. 
In relation to a prognosis, the findings of a pathological exami-
nation are of outstanding significance. The giant-cells of epulis type, when 
present in excess, are a true indication of the benignity of the lesion. The 
typical giant-cell tUJDor where the giant cells form the bulk of the tumor is 
of very slow growth, not aggressive, and easily eradicated even by incomplete 
curettage. On the other hand, with the disappearance of the giant cells and 
with an increase in the number of spindle cells of the stroma, the aggressive-
ness of the tumor increases. Viewed largely, the type of cells of the stroma 
are of greater importance than the giant cells. Recurrence can be expected 
when the hyperchro.matism of the stroma cells occurs and also when the stroma 
cells have become abundant and rounded. However, pleomorphism and cellu-
larity in tlle central portion of a giant-cell tumor are not of such unfavor-
able significance for the prognosis as their presence in the peripheric 
portion or the tumor, where they notoriously mark aggressiveness. A guarded 
prognosis is to be given also in the case of the very vascular, so-called 
telangiectatic, giant-cell tumor which as a rule is more aggressive and 
recurs more frequently than other types. 
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While in :malignant bone tumors the problem of therapy today is to 
find a way to relieve the sufferings of the patient for a longer period of 
time, in giant-cell t'UJllOr, the whole crux of the question is as to choice 
between various methods of treatment, each of which may lead to permanent 
cure. The history of the therapy of giant-cell tumor is remarkable for the 
continuous change from radical to more conservative methods of' treatment. 
Bryant (19) reports a case of a young woman treated in 1861 by 
amputation of' the thigh who was still alive after seventeen years. Dr. 
Gross (41) in 1879 treated these tumors by amputation when permitted, and 
occasionally excised when the more radical measures were refused. He con-
eluded that although surgical interference was followed by a mortality of 
31.25%, it frequently succeeded in preventing local and systemic infection 
as well as prolonging life. He was of the opinion that because of the diffi:-
culty in determining the true nature of' the neoplasm in its incipient stages, 
delays were' extremely dangerous, s-i.nce, instead of having to deal with pure 
Dtifeloid sarcoma (giant-cell tumor), the disease might eventually prove to be 
an osteoid sarcoma, or a small celled medullary sarcoma, in which events, 
valuable time would have been lost, and the patients would have been exposed 
to the dangers of local infection and general dissemination. Inste~d of am-
putation, excision bf an entire joint, or of the affected epiphysis, along 
with the shaft, of the more slender long bones were resorted to, particularly 
if the tumor presented a uniformly smooth surface, and was of a firm, dense 
consistence or was enclosed in an osseous shell. In cases of doubt, excision 
was commenced, and removal of the limb was substituted, if the capsule of the 
tumor was discovered to be perforated, and the sgft parts infiltrated by the 
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morbid product. The mortality rates were high because of the profuse hemorr-
bage encountered near the seat of the tumor, the high percentage of post-
operative infections, and the number of malignant sarcomas which were diagnosed 
as myeloid sarcomas (giant-cell tumors) with death ensuing from subsequent 
lung metastasis. Towards the end of the ninteenth century the benign nature 
of the giant-cell tumor became more widely accepted and the more conservative 
resection method gained its group of supporters, headed by Dre. v.Bergmann, 
Mickulicz and v.Bramann (9). Hinds (47) in 1898 reported a case of myeloid 
sarcoma (giant-cell tumor) of the femur treated by scraping. The dark red 
and firm growth was scraped out with a sharp spoon. The surface of the cavity 
was scrubbed with chloride of zinc solution (grains twenty to the ounce), and 
was packed with cyanide gauze. At the end of six weeks, because of unsatis-
factory granulations, the cavity was again scraped out and scrubbed with 
zinc chloride solution. The patient made an uneventful recovery and was in 
excellent general heal th 1 with a slight deformity of the knee, after a period 
of three years. In 1916 Dr. Hinds (13) 1n a personal communication to Dr. 
Bloodgood enclosed a letter from the patient written twenty-one years after 
conservative operation. The patient had perfect function and worked as a 
forester cutting down trees, carrying heavy weights, and walking from ten to 
twelve miles a day. An x-ray print (12) was also sent, demonstrating that 
the cavity was filled with bone. Dr. Bloodgood (10), 1n 1903, reported a case 
of a medullary giant-cell sarcoma (giant-cell tlDllor) of the upper end of 
the tibia in which the tumor was apparently completely removed by chiselling 
without destroying the continuity of the tibia. The entire bone cavity was 
curetted and swabbed with pure carbolic acid, followed by alcohol, then 
irrigated with 1:1000 bichloride solution, followed by normal salt solution. 
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Horsely's wax was used to check the bleeding in the cavity. The patient was 
in good health and almost complete function was restored in 1903 - one and 
one half years later. 
In 1891 the curative effect of accidental erysipelas in inoperable 
sarcoma was observed by Dr. Coley (22). In 1893 he began the use of toxins 
of erysipelas and Bacillus prodigiosus in the treatment of inoperable bone 
sarcoma, and s.oon after that used them in operable cases as a prophylactic 
against recurrence, after amputation. He reported in 1909 the successful 
use of the mixed toxins in 52 cases of inoperable sarcoma. With such ex-
cellent results in inoperable cases, the mixed toxins of erysipelas and 
Bacillus prodigiosus were used as an adjunct to treatment with gratifying 
results. Dr. Coley ( 23) says, regarding the use of mixed toxins in the more 
benign lesions of bone,"while good results have been obtained from operation 
alone in a limited number of cases in this group, ;r am convinced that the 
number of successes will be greatly increased by qombining the toxin treat-
ment with conservative operation". Dr. Bloodgood (12) agrees with». Coley 
that his serum should be used in all inoperable c~ses, that it should also 
be used before and after operable cases when the ~arcoma is of a type which 
experience has shown to be very malignant, and in iwhich few, if any, cures 
have been accomplished. He cites twenty-six case~ of giant-cell tumor in 
which there was no treatment other than removal o~ the tumor by curette, 
excision, resection, or amputation, and in no case was there a recurrence or 
metastasis of the disease. He is of the opinion ~hat there is no more reason 
for giving a patient with a true giant-cell tumor jcoley' s serum, x-ray, o:; 
i 
radium treatment, than to employ them for lipoma., lexostosis or any other type 
of benign tumor. ! Bloodgood's (12) conclusions as !to the conservative 
treatment are as follows: 
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1. Conservative treatment is justifiable. Curetting should in 
some localizations of the tumor, be the operation of choice. But in those 
localizations where resection in continuity does not interfere with func-
tion, resection becomes the operation of choice; for example, upper end of 
fibula, lower end of ulna. 
2. It is justifiable to attempt curetting to preserve function 
even when conditions suggest a great probability of recurrence. There is 
no position where curetting is not justifiable as a first attempt. It has 
succeeded when the entire lower end of the femur was involved. 
3. The number of successful cases of curetting will depend chiefly 
on the number of attempts. 
4. After curetting or resection, the wound should be disinfected 
with pure carbolic acid followed by alcohol or chloride of zinc solution. 
Thermal cauterization may replace chemical cauterization. The operation 
should always be done, if possible, under an Esmarch. This procedure is not 
indicated because of the malignancy of the giant-cell tumor, but because in 
curetting disseminated cells are left, while in resection, cutting into the 
tumor may inadvertently be done. qf FI "" 'lo a 
t pk blntb Mt&J sa;sab khe ; ·'ta• h • 1 a••••••••• aa• ''I 21 mire 
LEI bl*/ Hitzrot (48) states that recurrences have been more frequent 
when this h~s been incomplete or has not been followed by cauterization. 
5. It is not necessary to perform the bone transplantation at the 
primary operation unless a single bone like the humerus or femur is divided 
in its continuity. In simple cases there is no reason why the transplanta-
tion should not be performed at the same time, but in some cases the resection 
may be tedious and bloody, and the patient may not be in good condition. In 
such cases it will be safer to transplant at a second operation. 
• 
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6. It is simpler, when possible, to get the bone for filling the 
defect by splitting the bone which has been resected. This can be accom-
plished through a single wound. When this cannot be done on account of a 
large defect, one can remove the upper third of the fibula without injury 
to the function of the limb, or chisel large pieces from the tibia without 
destroying the continuity of the bone'? The treatment of giant-cell tumors 
of bone by means of the roentgen ray covers a period of at least twenty-five 
years. Dr. Pfahler (78) in 1906 was the first to treat such a case. A 
roentgenological diagnosis of osteo-sarcoma was made. A section removed for 
microscopical examihation was diagnosed as a round cell sarcoma. The patient 
1 was given intense roentgen ray treatment and was symptom free after three 
months. After a year and a half the bony tumor was only reduced to two thirds 
of its original size. This was reported as "the first case that has been 
observed Roentgenologically during the process of recovery from an osteo-
sarcoma". Dr. Pfahler (79) reviewed this case in 1932 and reported that, 
"it showed begjnning lime deposit at.. the end of a month, and progressive 
improvement from that time onward, during at least fifteen years, and is 
known to be well for twenty-five years. At the end of this time the bone 
completely recalcified but remained about 25% larger than normal". The clin-
ical, roentgenological, and microscopical diagnosis was "sarcoma", but in 
retrospect these "cured sarcoma.ta" are now recognized as having been giant-
cell tumors. 
Dr. Herendeen (43) in 1924 wrote his first of a series of articles 
dealing with the roentgen-ray treatment of bone tumors, recording the changes 
noted in giant-cell tumors following treatment with the roentgen ray or 
radium, and comparing briefly the value of these agents with the standard 
surgical methods of treatment. 
43. 
The cases treated at the Memorial Hospital from 1919 to 1924 were 
grouped as follows: Group I, consisted or those cases in which no operation 
was performed. (In two or three instances incision for biopsy was done.) 
Group II, consisted of those cases referred for treatment on account of re-
currence following operation. Group III, consisted of those cases referred 
for treatment to pPevent recurrence after operation. In the majority or the 
cases representing Group I, the roentgenographic features were so character-
istic that the diagnosis was made without the aid of a biopsy. The changes 
observed, following treatment, were largely in those cases in which there 
had been no incision into the tumor. In addition to the cases in Group I, 
seven cases were treated on account of a recurrence and five to prevent re-
currence after curettage. 
These figures emphasize two things: of the cases of giant-cell 
tuaor admitted to the hospital, about 15% applied for treatment to prevent 
recurrence, on advice of their surgeons, who apparently realize the diffi-
culty of removing all of the tumor tissue; about 20% applied for treatment 
for a recurrence - some cases having a recurrence after two or three curette-
aents or attempt at local removal. Plates made from one to two months 
following treatment have revealed in almost every case the same reaction, 
which consists in rapid enlargement of the tumor, with expansion or the 
cortex and a thinning out of the bony capsule or the tumor, until hardly any 
of the outline is visible. Prior to the demonstration of these changes in 
the roentgenogram, the skin becomes reddened-, and the parts swollen and soft 
or edematous to the touch. As time goes on the redness and swelling subside, 
the tumor becoaes firm to the touch, and a roentgenogram then reveals a re-
turn of the outline of the tumor, with evidence of the production of bone or 
deposit of calcium in its capsule. The function of the part returns, pain 
,,....,I 
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disappears, and the tumor feels firm or stony hard. A plate made later dis-
closes increasing densit7 and calcification, and later still the entire mass 
seems converted into almost solid bone. 
During the stage of reaction - that is, a month or two after the 
first treatment is given - the tumor has all the appearance, both clinically 
and roentgenographically, of a rapid increase in growth. Most surgeons and 
others unfamiliar with the changes induced by the roentgen-ray treatment, 
assert that it is a failure, and the assertion is also made that it stimulates 
the activity of the growth, hence immediate operation is advised. If, how-
ever, at the end of another month or two., the patient is examined and a roent-
genogram is made, it will be found that the reaction has subsided, that the 
tumor is becoming ossified, that pain is relieved and function is returning, 
and there is present a well-marked effort of a healing process. Up to the 
time of the writing of this article by Herendeen, sixteen cases of primary 
giant-cell tumor of the bone had been treated at the Memorial Hospital with 
the roentgen-ray or radium alone. All of these cases were filed at Boston in 
the Registry for Bone Sarcomas. The oldest case was treated in 1918 and was 
apparently cured in 1924. Eight of the thirty-six cases studied were classi-
fied as a typical, undetermined, or as tumors simulating giant-cell tumors. 
This figure emphasizes the frequency with which one encounters variations from 
the typical or characteristic giant-cell tumors. Herendeen summarizes his 
first article by saying, "It does not seem premature or too optimistic to say 
that it is believed that most of them can look forward to a complete cure and 
restoration of function. It may be that in some of the more advanced cases 
only a retardation or a halt in the growth with firm encapsulation and without 
dense ossification will result from the treatment; but if so, these cases 
will be in a much better position for curettage than they were prior to the 
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radiation, and it does not appear unwise, before advising a patient to submit 
to an amputation on account of the size and location of the t~or, and the 
fact that it may have broken through into a joint, to give roentgen ray treat-
ment a fair trial to obviate the loss of a limb by amputation." 
A follow-up of Herendeen's cases, previously cited, shows that all 
of those considered in the previous report continued to improve or have re-
mained free.or· ey: sign of recurrence or presence of actively growing tumor, 
except two. One case developed a recurrence, but, on treatment, responded 
favorably and the condition at this time is quite satisfactory. Another case 
was treated under a mistaken diagnosis and came to amputation. This tumor, 
when examined in the laboratory, was found to be locking in many of the 
essential features of a giant-cell tumor and resembled considerably what Ewing 
terms as a telangiectatic sarcoma. This patient is alive and well today with 
no evidence of the disease present. It shou:Ld be emphasized that the great-
est value of radiation in the treatment of giant-cell tumor appears to be in 
those cases where the tumor has so destroyed the end of a weight-bearing bone 
that the logical procedure is amputation. It is obvious that the va1ue of a 
simple curettement in such cases lies only in the ability to completely re-
move the tumor. This frequently cannot be, or is not accomplished. If, how-
ever, the tumor is completely removed, a shell-like cavity remains, so fragile 
that the limb is of no value for weight-bearing purposes. A number of such 
cases have been followed for a considerable period and it was only after a 
lapse of years that it has been possible to demonstrate in the radiographs 
the production of~ considerable quantity of new bone. Furthermore, the 
hazards of infection or destruction of the joint surfaces in such cases are 
considerable. There are numerous instances where curettement of a small tumor 
is the logical treatment, but even in these instances, it is doubtful, 
according to Herendeen, if radiation cannot accomplish as much as curettage 
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in the relief from pain and saving of time in restoring the limb to usefulness 
(44). Dr. Coley (25) believes with Dr. Herendeen that it is now possible to 
state definitely t~at giant-cell tum.or can be cured by radiation but disagrees 
with him on the period of disability. Coley is of the opinion that the time 
required to effect a cure by radiation is considerably longer than that re-
quired by operative treatment or by toxins, with or without curettage, and 
hence the period of disability is prolonged. The chief disadvantage of radi-
ation as a routine, primary method of treatment of giant-cell tum.or lies 
in the fact that in a considerable number of cases the diagnosis of benign 
giant-cell tumor cannot be made from clinical and roentgen-ray data1lone. 
Dr. Coley still firmly believes that it is possible to cure these cases of 
giant-cell tum.or most rapidly and certainly by surgery (curettage) followed 
by toxins. "This method," he says, "requires a much shorter period of dis-
ability and is not associated with greater risk". Platt (SO) and Cotton (28} 
believe that operation is absolutely preferable to irradiation. Cotton says, 
"I would go even further and say that irradiation usually acts to stimulate 
the tum.or growth, the curative effect beginning only later and at the expense 
of unnecessary deformity from loss of bone. He believes that only when such 
tumors are found in the spine (60) is the x-ray to be chosen as a means of 
treatment. 
Dr. Herendeen (45, 46) reports several cases in 1930 and 1931 to 
substantiate his statements that roentgen-ray therapy is perhaps best suited 
for the treatment of giant-cell tumors. Herendeen (46) states that there is 
no standardized method of irradiating these tumors. There is no roentgen-ray 
dose. The amount of radiation given to the tumor and the methods of deliver-
ing it vary with the case. Few of these tumors respond alike to the same 
dose of roentgen-rays. Radiosensitivity varies, as does that of other tumors, 
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with the presence or absence of many factors, which include age of the patient, 
location of the tum.or, rate of growth, and the local effort at growth restraint. 
It has been found that owing to the susceptibility of these tumors, they can 
be destroyed through the application of lighter doses which are not followed 
by an extreme degree of reaction. Bone regeneration seems to follow more 
promptly when lighter doses are employed. Special care should be taken during 
the early stage of the treatment of these tumors to protect the part from 
injury, and especially to protect the tumor from pressure in a weight-bearing 
limb, but it is seldom necessary to apply plaster splints, or to hospitalize 
the patient. 
In the knee joint cases, Herendeen (46) gives on the average of 
eight or ten treatments, a series consisting of three exposures, the exposures 
from three or four days to a week apart, the portals consisting in the exter-
nal, anterior and internal surfaces, using the so-called low voltage ;technic, 
140 kilovalts, 4 milliamperes of current, 4 millimetres of aluminum filters, 
12-inch target skin distance and from 12 to 15 minutes' exposure. An interval 
of approximately six weeks to two months is allowed to elapse before these 
treatments are repeated; but a great deal of variation occurs in the dosage 
and methods of delivering it. The roentgenologist must himself determine the 
amount to be given in each case at each treatment, and the decision as to how 
much to give and when to give it can be arrived at only through careful 
questioning of the patient, examining the part under treatment, and inspection 
and comparison of the radiographs:obtained from time to time. 
Pfahler (79) recommends the use of high voltage roentgen rays and 
filtration through 0.5 mm. Cu. When dealing with large bones, suc:h as a 
lesion in the upper extremity of the humerus or the lower extremity of the 
femur in a large man, the 200 kv. technique is essential. His technique in 
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the treatment or giant-cell tumors consists of fractional cases. None or the 
cases in Pfahler's series have shown the swelling, increased pain, and marked 
increase in the decalcified area such as has been reported by Herendeen (46)~ 
Pfahler and Parry (79) believe that such symptoms are due to the massive dose 
technique. Pfahler emphasizes that, "In osteogenic sarcoma, rapid saturation 
with radiation to the limit of normal tissue toleration is justified in order 
not to lose the radiosensitivity, but in giant-cell bone tumors this is not 
essential and one is less apt to interfere with the repair, or to set up an 
osteitis. This fact makes an accurate diagnosis essential." In general, 
Pfahler recommends treatment with high voltage roentgen rays, filtered through 
0.5 mni. of copper, at a distance of 50 cm., 25% skin erythema doses given 
successively through one, two, three or four fields of entry. If the case is 
clearly a giant-cell tumor, these treatments need not be given more than three 
times a week, but if there is any doubt, the treatment should be given daily 
until the tumor area has been brought to 100% of a skin erythema dose accord-
ing to the "saturation technique" of Pfahler. If a satisfactory diagnosis 
of giant-cell tumor is made, the treatment need not be crowded, but in all 
cases one must keep account of the total dosage, and not give sufficient to 
produce secondary degeneration. Degenerative effects are due to the total or 
cumulative dosage and may occur when no erythema has ever been produced. 
This amount varies with the location and condition of the soft tissues. After 
the treatment during three jeeks, one can allow an interval of about six weeks 
to two months and then re-study the case and treat accordingly. 
The most common site for giant-cell tumors is in the ends of long 
bones, and therefore when they occur in young children they are in the 
neighborhood of the epipbyses. For this reason, many physicians hesitate to 
have these cases treated by irradiation. However, Borak, after reviewing all 
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of the records, concludes that.no normal bone has_been found damaged in any 
of the cases unless there has been some damage to the-overlying tissues. 
Pfahler and Parry (79) have also found this to be true. Of the twenty-six 
cases of giant-cell bone tumor which have been referred to ~hem for treat-
ment between 1906 and 1931, all cases have shown a definite and satisfactory 
response, more satisfactory in the young than in the adult. 
In 1932 Dr. Carleton Peirce (76)(77) reviewed the nineteen cases 
of giant-cell tumor which were diagnosed as such by the Department of Roent-
genology of the University of Michigan from 1924 to 1932. This group does not 
include any with involvement of either maxilla or :mandible. Fourteen of these 
confirmed by histopathologic study are analyzed, ten considered clinically 
cured, two presenting malignant features. They found that roentgen irradi-
ation in repeated relatively moderate doses offers the most for the patient, 
except when for cosmetic or functional reasons better results could be ob-
tained with the addition of surgical intervention. Surgical intervention 
should not follow roentgen therapy short of six weeks to two months. If 
surgery is contemplated, thorough curettage and equally thorough chemical 
cauterization of the cavity should be executed, followed immediately by a 
consistent roentgen therapy program (74). 
__ LeWold (59), Kraft (57), Evand and Leucutia (33) and Desjardins (30) 
have als9 reported the successful use of roentgen ray therapy in these giant-
cell tumors. The use ol radium in the treatment of giant-cell tumors has not 
met generally with much success, however, Coley (26) reports a case success-
fully treated with a radium pack and Coley's toxins. The high cost of a ra-
dium pack makes its use almost prohibitive in the average institution. 
Hitzrot (48) believes that the implantation of radium as a part 
treatment in curettement is not advisable because of the delay in healing 
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produced by the action of the radium. 
It is very generally believed that it is possible to make a correct 
diagnosis of giant-cell tumor from the clinical and roentgenologic evidence 
alone, but Coley (26) shows that records at the Memorial Hospital and the 
Hospital for Ruptured and Crippled have proved that to rely on such evidence 
alone results in error in about one out of every five cases, or, in twenty 
per cent. Inasmuch as such an error may result in the loss or life or the 
patient, it is not justifiable in taking such a risk if there is any safe way 
by which a correct diagnosis can be made before treatment is begun. ·While·it 
bas now been proved that giant-cell tumors of the bone can be cured by roentgen-
ray, by no means can all such cases be cured by radiation. The chief objec:.. 
tion to radiation as the method of choice is that it is not always possible 
to be certain that a given tumor is a benign giant-cell tumor, and if radi-
ation is continued indefinitely in such a case, metastasis may develop before 
the error is recognized. Hence, the importance of making a correct diagnosis 
early in all cases of central tumor of the long bones justifies an exploratory 
operation, and far outweighs all the disadvantages associated with such 
exploration. 
This exploration should not be a mere biopsy, and should be under-
taken only by the surgeon who is to have future charge of the patient, aiid who 
has had sufficient experience with bone tumors to enable him to carry out the 
most careful surgical technique. In all cases of giant-cell tumor, the entire 
tumor should be curetted down to healthy bone, and the cavity swabbed out 
with zinc chloride. Therefore, the so-called exploratory operation is not a 
biopsy but, is the method of choice to be employed in the treatment of giant-
cell tumors. In this opinion of Coley's (26), Bloodgood (13) and most surgeons 
here and in Europe concur. 
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If the microscopic examination shows that the tumor is of a defi-
nitely malignant, metastasizing type, then amputation can be performed, 
following this with prophylactic toxin treatment. The use of toxins after 
curettage for giant-cell tU1Dor is advocated by Coley but declared unnecessary 
by Bloodgood. 
To substantiate their procedure for treatment Coley offers a brief 
resume of a series of cases, diagnosed as benign giant-cell tumor from clini-
cal and roentgen ray evidence, wh~ch later proved to be malignant. It is 
interesting to note that one of these cases was selected from all the giant-
cell tU1Dors obs.erved at the Memorial Hospital, and included by Dr. Kolodny 
(55) in his admirable and exhaustive review of the Bone Sarcome Registry data, 
as a typical examination of giant-cell tumor. 

CASE I 
• 
CASE I 52. 
llra. lt.K., age 25, white, entered University Hospital on 3/12/JJ 
.coaplainiDg 01·: 
(l) Pain below left knee :ror six months 
(2) Graduall:T inereasing t1801" mass bel.ow lett knee 1·or su: months. 
Bistorz:- Trauma to iert knee area in 1931 with considerable pain. 
Condition apparent.17 cleared With no known complications. Trauma to same 
area in October 19J4':! wi~h resulting 1·racture or upper portion 01· lert tibia. 
Roentgenogrus taken in December 1932 because ot· aoderate enlargement at 
site or fracture. Diagaosis o:r bone C)"st aa.de at that time. This mass showed 
progressive enlargement With considerable pain in area even When leg 1-obile. 
Exaa1 pation:- Nodular enJ.argeaent on antero-latera.l. sur1·ace or 
upper iert tibia about the size or .ba.lf a nl.nut. Circumference below let't 
patella - 14 inches. Circuarerence below right patella - 13 i/3 inches. 
aoentgenographT:- 3/13/33 Radiographic studies ot the left knee 
deaonstrates a large CJStiC area .invol v1Dg more than halr the diameter 01· 
the upper end ot' the t1.bia which shows a pushing out of tae cortex which is 
markedl7 thinned. along the lateral. and superior aspect of the external pla-
teau. There is evidence of ce..U.ular partitions extending through portions 
of the eystie area. There has been no e.rfort at new bOne rormation, the 
lesion being primarily a destructive ~esion. 
3/16/33 Bo eVidence or metastasis involving the 
skeletal structures or tbe lung tields. 
Operative proeedures:-
3/14/33 - Drs. Lord and Johnson attending. Small incision 
aa.de two inches Jateral.q below pate.la and laterall7. The t1Jll0r had prac-
tieal.:cy' eroded ~brough the tibia nil and contained rroa 50-100 c.c. or 
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•Ri-llql11d. •terial •1th rriable tisne Wb.ich was remc>Ted. Cavity- swabbed 
with iodine and packed •ittl iodine saturated gauze. 
3/23/33 - Dr. Lord attending. Incision -.de over the head ot 
the fibula on tbe lett leg. 'l'mor carlt1 opened and about 40 ce. of soft 
semi gelatinous tumr tissue was scooped out. This cavity- connected with 
the primary carlv in the tibia. Bo1'l cavities nabbed 1fi th Tr. ot Iodine 
and tilled with llosteg-llorhott boae 1f8.X because or extensiYe hemorrllage. 
One container of radium was placed in the center or the wax in the tibial 
cavity and one in the tiblilar cavity. Wound lett open. 
Pathological report: 
Gr:osa: SeYeral masses or red he110rrhagie tissue in which are 
seen yellowish-gray nodular pieces or tissue. 
ll1croscopJ&1 Extensive he110rrhagic areas, some areas showing 
giant.Mell roration, other areas shoring more fibrous tisaae, with compara-
tiveq llllitom sized spindle-shaped cells. In these areas giant cells are 
comparatively few in nmber. Giant cells muck more numrous in areas showing 
degeneration and where :belaorrhage is particularly extensiTe. 
Diagnosis:- Osteogenic sarcou. 
4/25/33 - Microscopic sections reviewed by Dr. Bloodgood and 
Dr. Toll.man - diagnosis changed to benign giant-cell t1B0r. 
X-Baz Theraw: 
3/26/33 - University Hospital - Dr. H. B. Bunt. Total 3000 mg. 
hours through 1 ma. Brass, 2 ... Lead, and three-tenths Platinu was given 
through 2 Lead capsules in the head of the tibia. 
3/30/33 - Methodist Hospital - Dr. B. B. H1B1t. 5x100 R, 
t Copper, 1 Alulli.n•, Ant. , Post. , Lat. , and Med. of upper 1/3 tibia. Inten-
sive x-ray therapy given over the lesion, directed through four parts. 
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Progress: 
2/8/34 - Check-up x-ray taken:- Tuaor has not increased in 
size following operation and radiation. Eff'ort at bon;y repair seen. 
The patient waa 'Up and about tor oYer a year apparently 
s)'JIPtom free, UDtU 118.7 1934, when this area again became painful. Re-
adaitted to University Hospital JUDe 26, 1934 because of' severe pain 1n 
knee area with profuse draillage. 
3/26/34 - Biopsy taken - negative soft tissue. 
7/12/34 - Amputation at lower third or fenr. 
7/12/34 - Biopsy takell - DO evidence of' tUJ10r intiltration 
in section through skin, llUSCle and regional l1J1.Ph glands. 
Discussioa: This case is unique in its completeness of compli-
cations, in spite or judicious treat.ment and obsenance of every precau-
tionary •&sure. Trauma preceded the recognition or the tumor by owr one 
year. Pain and enlarge•nt with x-ray plates .revealed the tllllOr. Tlds case 
illustrates the ditticulty in •king proper diagnosis even with biopsy. The 
original biopa7 report was. osteogenic tumor, althaugh clinical and x-re:r 
evidence tended toward giant-eell tumor. This biopq report was later changed 
atter consultation with Dr. Bloodgood. The estre• hemorrhagic condition. ot 
the tUJIOr necessitated the use of' bone wax. This condition in itself makes 
curette•nt very difficult and because of' the extreme danger or inf'ection, 
under the most aseptic conditions, the use of' roentgen theraw, in favorable 
eases, where diagnosis is evident, is to be recommended because it obviates 
these collpl.icatiollB. 
The recurrence of' tumor tissue, well illustrated in this case, is 
probably due to incomplete curettage. With extensive involvement of' the 
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tuaorous area, and profuse hemorrhage at operation because or the telangi-
eetatic condition or the tis8118• it is easy to realise the difficulties 
confronting the surgeon in his attempt to complete17 eradicate all tumor 
tissue. 
This recurrence of tissue, loss of weight bearing due to extensiTe 
inYOlTement of the tibia and fibula• and possible local malignant changes, 
made amputation aboYe the knee a most advisable procedure. 
The patient is in good general health at present, repeated roentgei:l 
plates failing to show~ metastatic nodules. 
fl -3-33 
CASE II 
CASE II 
Jlrs. c.c., age 21, white,seen by- Dr. Berman Johnson, presented 
the following complaints: 
(1) Progressive swelling of the lower forearm for twelve months. 
(2) More rapid growth dving the past five months while the patient 
bas been prepant. 
56. 
P!Jsical En•i•tion: Fusitora enlargement of the distal end ot 
the forearm on the ulnar side, fira to pal.pa.tio11. 
Roentnnologigal enndnatioa: 5/9/.3.3- Roentgenograms show a cystic. 
trabeeulated expansion of the distal end ot the ulna measving ~ ea. 
with Tery pronotm.eed rarefaction of bone through the region ot expansion. 
Diynosis1 Giant-cell tU110r of the distal end of the ulna. 
Therapeutic m;ocedursn It was decided to treat the case by- radi-
ation and to allow the patient to return tor surgery in case a satisfactorT 
result was not ol>'f;ained. 
Radiation »mm 5/28/.3.3 - .350 R- units of radiation was deliv-
ered into the tmor through ulnar, dorsal, radial and volar po!'ts, delivering 
about 1190 R- •its into the tumor itself. The radiation was energized 111' 
200,000 YOlts, fil'\ered through I cu. and 2 mm. Al. at a distance of 60 ca. 
The patient returned after one week for tU'E'ther radiation. (Re-
calcitication is not to be expected for a period or about three months and 
during the three weeks di:rectl.J f ollowiltg therapy there ay be slight tU'E'ther 
lysis of bone) 
ll/20/.3.3 - Patient returned showing a subsidence or the swelling 
of the distal right ulnar region and showing slight brownish pigmentation in 
the oTerlying skin. The circmlterenee of the forearm· at a level two inches 
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above the wrist measures 6f iDchea at this time. 
Further A.P. and lateral radiographs show the cyst to haTe shr'IJllk 
to about half its pr'eTious toi..l volume. It now measures about 2 • .3 •· in 
diameter and is 7 cm. in total length. The qst originall.7 measured about 
3.5 cm. in diameter and 7 cm. in length. In addition there has been a 
cle.tinite increase in calcification through the cortex and along the trabecu-
lation witldn the c;yst. 
:Wo further radiation was giTen. 
Discusion: Thia case was included to illustrate the very satis-
taetor;y results obtained b;y radiation therap;y in selected cases. Radiatioa 
therap;y is indicated in clinical and roantgenological positive giant-cell 
t..-ors. Best results are obtained where radiation is given 'irithout the 
deleterious ettects ot surgical interference tor biopS)". 
The cosmetic effect is not as good as might be obtained b;y curettage, 
but radiation is preferable to this more radical procedure when the knee area 
is extensivel;y involved, necessitating resection, bone grafting, prolonged 
disabilit;y and of'tentiaes loss o:r tmction. 
Adldttedq, each case is an individual problem. and the inn\11lel'able 
factors involved call tor different lines of attack. 
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llr. E. •eL., ml.e, age 60, seen by' Dr. Robert D. Schrock. 
Riston: Fracture at wrist in 19.30. Wrist splinted. Patient 
went to work four JDOnths later. Swelllng continued to slowly increase in 
sise. Injury to this area again in 19.3.3. lo piln present except rheumatic 
pain, not COJttined to this area alone. 
§mtou: Progressive enlargement of distal third of right fore-
arm on the radial side. GraduaU7 increasing def'ormit7 and d78f'unction. 
1'o pain. 
aoentgepolo&ical W$&ti91: Roentgenograms reveal large, single, 
cystic trabeculated expaneion of' the distal end of the right radius, with 
Teey pronounced rarefaction ot bone through the region of expansion. A 'Very 
thin la7er of' increased density is seen surrounding the expansion on the 
ulnar side, and at the base or the radial side. This is probabl.J' a verr 
thin cortical capsule. There is no evidence of the shaft seen through the 
expansion. The ulna is displaced •dialJ.7 and distallJ'. 
Diamosis: Giant-cell t1111or of' distal third of right radius. 
Discussion: This case was included to illustrate the sillplicity" 
of diagnosing a trul.7 t;n>ical giant-cell tuaor b7 roentgenological and 
clinical enllination. The historJ" is typical - t.r&U1118. and slow progressiTe 
increase in size of the t-.or, but the absence or pain and advanced age of 
the individual teach a lesson ih theuelws 1 ~ illustrating that textbook 
8191>to11S and generalities nst not be adhered to dogmaticall7. The absence 
of one or JDOre typical findings must not overweigh the bulk of proof. 
CASED( 
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Jira. W.R.M., feale, age 21, entered the offices of' Drs. Lord, 
Schrock and JQ)nson on April 16, 1934 because ot pain and swelling in the 
right wrist area. 
Bistoq1 Pain in right wrist since autum of 193.3. lo histo17 
of' previous trauma. Slight swelling in area. 
Sng>t.pa: Pain and swelling in right wrist. Some limitation of 
llOtion. 
Plg!ical emnation: Enlargement of' distal third of right radius. 
Roen'f;genological ua•iMtiop: Radiograms skow a C7Stie trabecu-
lated area iaTOlYing the epiph7sial portion of the ript radius. This area 
of expansion is surrounded by a thin line of' dense •terial having the same 
density as the cortical bone. A fracture of the articular cartilage is seen. 
Clinical and roentgpol.odcal diaposis1 Gian~ell tmor of' radius. 
Operatin procedure: Dr. Schrock attending. Radial incision made. 
Egg shell cortex found surromding single cavity containing jelly-11.Jce sub-
stance grossl7 resembling giant-cell ttm>r tissue. Cavity cleared, •.etller 
pack inserted. Articular cartilage and dorSUll ot cortex fractured to prevent 
radial deviation. An 1-ediate bone graf't troa the ili• was transplanted 
to the defect, becaue of the insuf't1cient strength in the cortex to main-
tain the proper position of the wrist upon the forearm. The graft was 
drilled ten or twelve ti.Ms to permit early vasclllarization. The egg-shell 
cortex was then tinily collapsed upon this drilled, spongy bone. Moulded 
splint imllObilization.. 
Microscopic exa•inatioa: Specimen consists of' light bran :material 
troa a bone cyst in the torearm. Several eections show numerous giant cells 
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containing large B1111bers ot nuclei, an iDf'law:tory reaction, and moderate 
aononuclear reaction. Some areas are t)1>1call.7 infl.ammatoey, while others 
are masses ot giant cells in a tibro118 •trix. 
G£oss J?!tllo1ou: Taor showed characteristic thinning of cortex 
soll&What egg-ahell in appearance, but a little more ..ascular than the true 
bone cyst. · The contents were rather well organized granulation-like tissue, 
fairly ..ascular and with a detinite limiting membrane. The articular 
cartilage of the radius showed nicel7 the fracture deaonstrable in x-ra7 
together with the tracture on the dorsal surface. 
Patho1odeJ. diamosis: Giant-cell tumor of bone. 
Progreu: 
I"""-- ,- ll/23/34 - Roentgenograu meal graft bas healed. Position 
good. lo signs of recurrence. Wrist tends to fiexion. Placed in cock-up 
splint. 
3/15/35 - Wrist colling into dorsi-tl.exion position nicely. 
Band used aetiv817 and in excellent condition. 
Discussioa: This case is included to illustrate the excellent 
results obtainable in favorable cases by surgical procedures. It is well 
to add in this connection, that the surgeon should be well trained in or-
tllopedic procedures, to transplant bone gratts i:t necessary, to •int.a.in 
proper anatoaical relationships or to provide the best functional position 
it permanent fixation is inerltabl.e. 
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